143 related articles for article (PubMed ID: 6286510)
1. Reaction of 99mTc-diphosphonate with N-donor ligands.
Johannsen B
Int J Appl Radiat Isot; 1982 Jun; 33(6):429-32. PubMed ID: 6286510
[No Abstract] [Full Text] [Related]
2. New diphosphonate compounds for skeletal imaging: comparison with methylene diphosphonate.
Subramanian G; McAfee JG; Thomas FD; Feld TA; Zapf-Longo C; Palladino E
Radiology; 1983 Dec; 149(3):823-8. PubMed ID: 6316414
[TBL] [Abstract][Full Text] [Related]
3. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. New vistas on bone scintigraphy.
Nucl Med Commun; 1984 Jun; 5(6):359-60. PubMed ID: 6241663
[No Abstract] [Full Text] [Related]
6. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
7. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
8. Technetium-99m complexes of dimethylaminomethylene diphosphonate (DMAD)--II. Biological distributions of 99mTc-DMAD components isolated by anion exchange HPLC.
Holland ME; Bugaj J; Heineman WR; Deutsch E
Int J Rad Appl Instrum B; 1989; 16(3):313-7. PubMed ID: 2497091
[TBL] [Abstract][Full Text] [Related]
9. [Clinical studies on bone deposition of 99mTc-labeled-DPD (dicarboxypropane diphosphonate): a comparison with 99mTc-methylene diphosphonate].
Otsuka N; Yoneda M; Sawai M; Saito J; Nagai K; Muranaka A; Terashima H; Yanagimoto S; Ito Y
Kaku Igaku; 1982 Dec; 19(10):1573-8. PubMed ID: 6221135
[No Abstract] [Full Text] [Related]
10. [Clinical studies on the detection of bone metastasis in lung cancer by bone scintigraphy].
Nakano S; Hasegawa Y; Kajita A; Nakamura S; Horai T; Ikegami H; Matuda M; Okamoto N; Nabeshima H; Doi O; Komatubara Y; Ishigami S
Kaku Igaku; 1983 Feb; 20(1):37-43. PubMed ID: 6308314
[No Abstract] [Full Text] [Related]
11. Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
Kobayashi H; Shigeno C; Sakahara H; Hosono M; Hosono M; Yao ZS; Endo K; Konishi J
J Nucl Med; 1994 Sep; 35(9):1482-4. PubMed ID: 8071696
[TBL] [Abstract][Full Text] [Related]
12. Diphosphonate bone scanning agents--current concepts.
Fogelman I
Eur J Nucl Med; 1982; 7(11):506-9. PubMed ID: 6217074
[TBL] [Abstract][Full Text] [Related]
13. The bone scan as a tumour marker in prostatic carcinoma.
Chisholm GD; Stone AR; Beynon LL; Merrick MV
Eur Urol; 1982; 8(5):257-60. PubMed ID: 6288389
[TBL] [Abstract][Full Text] [Related]
14. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
[TBL] [Abstract][Full Text] [Related]
15. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
16. Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Weber DA; Makler PT; Watson EE; Coffey JL; Thomas SR; London J
J Nucl Med; 1989 Jun; 30(6):1117-22. PubMed ID: 2544697
[No Abstract] [Full Text] [Related]
17. Skeletal scintigraphy with technetium diphosphonate in multiple myeloma--a comparison with skeletal x-ray.
Lindström E; Lindström FD
Acta Med Scand; 1980; 208(4):289-91. PubMed ID: 6449830
[TBL] [Abstract][Full Text] [Related]
18. What do we want from a bone-scanning agent?
Fogelman I; Bessent RG
J Nucl Med; 1980 Mar; 21(3):296. PubMed ID: 6445001
[No Abstract] [Full Text] [Related]
19. [Quantification in bone scintigraphy with Tc-99m-phosphonates: determinants and data points].
Büll U; Reinartz P
Nuklearmedizin; 2000 Aug; 39(5):N69-71. PubMed ID: 10984892
[No Abstract] [Full Text] [Related]
20. Comparison of tc-99m MDP, HMDP, and DPD with respect to bone-to-soft tissue ratios.
Buell U; Kirsch CM; Kleinhans E; Jäger B
J Nucl Med; 1983 Dec; 24(12):1201-2. PubMed ID: 6227711
[No Abstract] [Full Text] [Related]
[Next] [New Search]